Solid Tumors
A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 510 Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and AMG 510 Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreak 100) (20170543)
- Details
ClinicalTrials.gov ID:
NCT03600883
Diagnosis Type:
NA
USOR Number:
- Address
4715 Arapahoe Avenue
Boulder, CO 80303
P: (303) 385-2068